Point72 Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-647,008
| Closed | -$1.1M | – | 1011 |
|
|
2022
Q2 | $1.1M | Buy |
647,008
+64,500
| +11% | +$110K | ﹤0.01% | 824 |
|
|
2022
Q1 | $1.2M | Buy |
582,508
+17,300
| +3% | +$35.6K | ﹤0.01% | 852 |
|
|
2021
Q4 | $2.12M | Buy |
565,208
+488,908
| +641% | +$1.83M | 0.01% | 764 |
|
|
2021
Q3 | $394K | Sell |
76,300
-1,982,792
| -96% | -$10.2M | ﹤0.01% | 881 |
|
|
2021
Q2 | $8.77M | Buy |
2,059,092
+80,858
| +4% | +$344K | 0.04% | 458 |
|
|
2021
Q1 | $10.5M | Buy |
1,978,234
+228,234
| +13% | +$1.21M | 0.05% | 395 |
|
|
2020
Q4 | $9.43M | Buy |
+1,750,000
| New | +$9.43M | 0.05% | 426 |
|
|
2018
Q4 | – | Sell |
-300,000
| Closed | -$4.07M | – | 825 |
|
|
2018
Q3 | $4.07M | Buy |
+300,000
| New | +$4.07M | 0.02% | 521 |
|
|
2018
Q1 | – | Sell |
-96,900
| Closed | -$647K | – | 764 |
|
|
2017
Q4 | $647K | Buy |
+96,900
| New | +$647K | ﹤0.01% | 688 |
|
|
2017
Q3 | – | Sell |
-545,500
| Closed | -$2.45M | – | 721 |
|
|
2017
Q2 | $2.45M | Buy |
545,500
+22,200
| +4% | +$99.7K | 0.01% | 527 |
|
|
2017
Q1 | $2.88M | Buy |
+523,300
| New | +$2.88M | 0.02% | 558 |
|
|
2016
Q1 | – | Sell |
-130,200
| Closed | -$1.57M | – | 640 |
|
|
2015
Q4 | $1.57M | Buy |
+130,200
| New | +$1.57M | 0.01% | 531 |
|